Company intelligence

FENC

Fennec Pharmaceuticals Inc. · NASDAQ · Healthcare

Price$10.18-5.04% · −$0.54

Market cap353.62MEquity value

P / E-78.3Trailing ratio

Volume231.63KLatest session

Market data

FENC price chart

TradingView

Related signals

1 min delayed

Browse public FENC signals with their source context and measured market impact. Open any signal for its permanent analysis page.

FENCMar 23, 2026-19.19% since signal

Fennec Pharmaceuticals Set for Positive Earnings Report on March 24

Fennec Pharmaceuticals (NASDAQ:FENC) is anticipated to report a profit of 4 cents per share in Q4, reversing last year's losses. Additionally, a recent settlement of patent litigation concerning PEDMARK may bolster investor confidence ahead of the earnings announcement.

View signal analysis

Research